CLS Exhibits Thermal Therapy Laser Ablation System at AdMeTech Annual Conference in Boston, USA, August 3-5

Clinical Laserthermia Systems AB (publ)will be exhibiting its TRANBERG®|Thermal Therapy System and single-use accessories at the AdMeTech Annual Conference this August 3-5, 2018. This year’s theme is, “PRECISION DIAGNOSIS AND TREATMENT OF PROSTATE CANCER.”

”CLS is pleased to participate in this year’s AdMeTech conference. Our TRANBERG Thermal Therapy System is well suited to support this year’s theme of Precision Diagnosis and Treatment of Prostate Cancer”. Some of the most innovative players in the field are participating in this conference,” stated Alan Weinberg, General Manager of CLS Americas. 

The CLS Thermal Therapy System is designed and optimized to be utilized in conjunction with MRI-guided laser ablation for prostate treatment. It is currently in clinical use at several well known clinical centers in the United States and at other hospitals in the U.S., Sweden, and other European countries. Clinical trials are underway at Toronto General Hospital in Toronto Canada. The study which is initiated by the hospital, in investigates prostate treatment with image guided FLA. It includes 25 patients and is expected to be finalized during 2020.

CLS estimates the total addressable market (USA / EU / Japan) for image guided focal laser ablation for prostate treatment to amount to about 500 000 treatments per year. 

About the CLS TRANBERG Thermal Therapy System

CLS developed the system for image guided high precision soft tissue thermal therapy and ablation procedures. The system can be configured for MR or CT/US guided procedures using tissue temperature feedback for precise therapy and ablation control. The system includes a desk-top mobile laser unit, new innovative non-cooled laser applicators, external tissue temperature probe sensors and procedure specific accessories.

Unique, Non-Cooled, Diffusing Fiber Technology

CLS utilizes unique, non-cooled, diffusing laser fiber technology to optimize heat distribution in tissue while eliminating the need for external cooling. The system also includes features designed to improve workflow and reduce procedure times.

More about AdMeTech

This press release has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version.

Lars-Erik Eriksson, CEO, Clinical Laserthermia Systems AB (publ)
Tel: +46 – (0)702 – 90 33 00   E-mail: lee@clinicallaser.se

Clinical Laserthermia Systems AB (publ), develops and sells the TRANBERG®|Thermal Therapy System and specially designed sterile disposable products for safe, gentle and effective treatment of cancerous tumors. The products are marketed for image-guided laser ablation and for treatment with immunostimulating interstitial laser thermotherapy, imILT®. The company, which is headquartered in Lund Sweden and have subsidiaries in Berlin, Germany and Boston, MA,USA, is listed Nasdaq First North under the ticker CLS B. Certified Adviser is Västra Hamnen Corporate Finance. Further information is available on the company’s website: www.clinicallaser.se